Purpose: Propofol may cause hypotension and the mechanism is complex. The present study was designed to determine the direct actions of propofol in medulla of cats.Methods: Mean systemic arterial pressure (MSAP), heart rate (HR) and cardiac contractility (dp/dt) were compared before and after administration of propofol through the femoral vein (2, 3 or 4 mg.kg ~), vertebral artery (I mg.kg ') or the lateral cerebral ventricle (0.5 mg.kg ~) in eight anaesthetized cats. To study the direct effect of propofol in medulla, pressor areas of the dorsomedial medulla (DM) and rostral ventrolateral medulla (RVLM), or the depressor area of the caudal ventrolateral medulla (CVLM) were first identified with electrical stimuli and then confirmed by pressure microinjection of glutamate (Glu, 0.25M, 30 hi) via a multibarrel-micropipette in 28 cats. One hour later, propofol (0.001%, 50 hi) was microinjected at the same site. Electncal stimulation and Glu were applied again to compare changes of SAP, HR and dp/dt with that of the control.Results: Propofol dose-dependently decreased SAP, HR and cardiac contractility. The percent increase of MSAP induced by Glu were reduced by propofol in DN (59 +_ 3 % r 13 • 2 %, n = I I, P < 0.0 I) or in RVLM (56 _+ 4 % vs 18 • 2 %, n = 9, P < 0.01 ). In CVLN, propofol slightly but not significantly increased the depressor responses elicited by Glu (-27 • 2 % vs -33 _+ 3 %, n = 5, P > 0.05).Conclusion: Our results show that propofol principally inhibits the vasomotor mechanism in the dorsomedial and ventrolateral medulla to effect its hypotensive actions.Objectif : Le propofol produit de I'hypotension par un m&anisme complexe. Cette Etude avait pour object~f de delimiter sur le bulbe du chat I'activit6 directe du propofol.M&hodes : La pression artErielle systEmique moyenne (PASM), la frEquence cardiaque (FC) et la contractilitE cardiaque (dp/dt) ont ErE comparEes avant et apr& I'injection de propofol dans la veine fEmorale (2,3 et 4 mg.kg '), I'art&e vertEbrale (I mg-kg -~) et le ventricule cErEbral lateral (0,5 mg'kg -~ ) chez six chats anesthEsiEs. Pour &udier les effets bulbalres directs du propofol, les zones vasopressives dorsomEdiane (DM) et ventrolatErale rostrale (BVLR) bulbaires, ou la zone vasodEpressive ventrolatErale caudale (BVLC) bulbalre ont d'abord ErE identifiEes par stimulation Electrique et confirmEes par micro-injection sous pression de glutamate (Glu 0.25M, 30 ml) I'aide d'une micropipette ,~ plusieurs barillets chez 28 chats. Une heure plus tard, du propofol (0,001%, 50 hi) Etait injectE au m~me site. I'Electrostimulation et Glu Etaient appliques encore une lois pour comparer les changements de PAS, le FC et de dp/dt avec ceux du contrEle.REsultats : DEpendamment de la dose, le propofol diminue PAS, FC et alp~tit. En pourcentage, I'augmentation de PASM induite par Glu Etait rEduite par le propofol dans DM 159 • 3 % vs 13 • 2 %, n = I I, P < 0,01 ) ou dans BLVR (56 -+ 4 % vs 18 • 2%, n = 9, P < 0,01 ). Dans BLVM, le propofol a augmentE IEg&ement mais non significativement les...